Mesenteric ischemia secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Mesenteric ischemia}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References== {{..." |
Feham Tariq (talk | contribs) |
||
| (20 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Mesenteric ischemia}} | {{Mesenteric ischemia}} | ||
{{CMG}} {{AE}} {{FT}} | |||
==Overview== | |||
Effective measures to prevent recurrence of mesenteric ischemia include screening by duplex ultrasonography, nutritional and life style modification, and drug therapy. | |||
==Secondary Prevention== | |||
The secondary prevention of mesenteric ischemia is similar to its [[Mesenteric ischemia primary prevention|primary prevention]]. | |||
Effective measures for the secondary prevention of mesenteric ischemia includes the following:<ref name="pmid9068664">{{cite journal| author=Klempnauer J, Grothues F, Bektas H, Pichlmayr R| title=Long-term results after surgery for acute mesenteric ischemia. | journal=Surgery | year= 1997 | volume= 121 | issue= 3 | pages= 239-43 | pmid=9068664 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9068664 }} </ref><ref name="pmid17573786">{{cite journal| author=Otte JA, Geelkerken RH, Huisman AB, Kolkman JJ| title=What is the best diagnostic approach for chronic gastrointestinal ischemia? | journal=Am J Gastroenterol | year= 2007 | volume= 102 | issue= 9 | pages= 2005-10 | pmid=17573786 | doi=10.1111/j.1572-0241.2007.01359.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17573786 }} </ref><ref name="pmid22305578">{{cite journal| author=Veenstra RP, ter Steege RW, Geelkerken RH, Huisman AB, Kolkman JJ| title=The cardiovascular risk profile of atherosclerotic gastrointestinal ischemia is different from other vascular beds. | journal=Am J Med | year= 2012 | volume= 125 | issue= 4 | pages= 394-8 | pmid=22305578 | doi=10.1016/j.amjmed.2011.09.013 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22305578 }} </ref><ref name="pmid19075493">{{cite journal| author=Tokgözoğlu L, Bariş Kaya E| title=Atherosclerotic vascular disease and risk factors in Turkey: from past to present. | journal=J Atheroscler Thromb | year= 2008 | volume= 15 | issue= 6 | pages= 286-91 | pmid=19075493 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19075493 }} </ref> | |||
* In patients with history of mesenteric ischemia, [[duplex ultrasonography]] is recommended after every 6 months for one year, and yearly thereafter. | |||
* All patients at risk of developing [[mesenteric ischemia]], should be educated about the signs and symptoms of the disease. | |||
* Patients who undergo [[Endovascular|endovascular repair]] for mesenteric ischemia should be recommended the following: | |||
** Lifelong [[aspirin]] and [[statin]] therapy | |||
** [[Clopidogrel]] for 1-3 months after the procedure | |||
** Lifelong [[Anticoagulant|oral anticoagulants]] in case of persistent atrial fibrillation, mesenetric venous thrombosis and inherited or acquired thrombophilias. | |||
** Nutritional status and body weight should be monitored | |||
* In cases of [[Mesentery|mesenteric]] [[Vein|venous]] [[thrombosis]], the causes of hypercoaguability should be treated. | |||
==References== | ==References== | ||
Latest revision as of 17:54, 19 January 2018
|
Mesenteric ischemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mesenteric ischemia secondary prevention On the Web |
|
American Roentgen Ray Society Images of Mesenteric ischemia secondary prevention |
|
Risk calculators and risk factors for Mesenteric ischemia secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Feham Tariq, MD [2]
Overview
Effective measures to prevent recurrence of mesenteric ischemia include screening by duplex ultrasonography, nutritional and life style modification, and drug therapy.
Secondary Prevention
The secondary prevention of mesenteric ischemia is similar to its primary prevention.
Effective measures for the secondary prevention of mesenteric ischemia includes the following:[1][2][3][4]
- In patients with history of mesenteric ischemia, duplex ultrasonography is recommended after every 6 months for one year, and yearly thereafter.
- All patients at risk of developing mesenteric ischemia, should be educated about the signs and symptoms of the disease.
- Patients who undergo endovascular repair for mesenteric ischemia should be recommended the following:
- Lifelong aspirin and statin therapy
- Clopidogrel for 1-3 months after the procedure
- Lifelong oral anticoagulants in case of persistent atrial fibrillation, mesenetric venous thrombosis and inherited or acquired thrombophilias.
- Nutritional status and body weight should be monitored
- In cases of mesenteric venous thrombosis, the causes of hypercoaguability should be treated.
References
- ↑ Klempnauer J, Grothues F, Bektas H, Pichlmayr R (1997). "Long-term results after surgery for acute mesenteric ischemia". Surgery. 121 (3): 239–43. PMID 9068664.
- ↑ Otte JA, Geelkerken RH, Huisman AB, Kolkman JJ (2007). "What is the best diagnostic approach for chronic gastrointestinal ischemia?". Am J Gastroenterol. 102 (9): 2005–10. doi:10.1111/j.1572-0241.2007.01359.x. PMID 17573786.
- ↑ Veenstra RP, ter Steege RW, Geelkerken RH, Huisman AB, Kolkman JJ (2012). "The cardiovascular risk profile of atherosclerotic gastrointestinal ischemia is different from other vascular beds". Am J Med. 125 (4): 394–8. doi:10.1016/j.amjmed.2011.09.013. PMID 22305578.
- ↑ Tokgözoğlu L, Bariş Kaya E (2008). "Atherosclerotic vascular disease and risk factors in Turkey: from past to present". J Atheroscler Thromb. 15 (6): 286–91. PMID 19075493.